Diabetic Neuropathy, Painful Terminated Phase 3 Trials for Tapentadol (DB06204)

IndicationStatusPhase
DBCOND0030279 (Diabetic Neuropathy, Painful)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01063868A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN)Treatment